Neogen Announces the Appointment of New Board Member

10/1/24 8:45:00 AM ET

$NEOG

$QGEN

Biotechnology: In Vitro & In Vivo Diagnostic Substances

Health Care

Biotechnology: Biological Products (No Diagnostic Substances)

Health Care

Get the next $NEOG alert in real time by email

LANSING, Mich., Oct. 1, 2024 /PRNewswire/ -- Neogen® Corporation (NASDAQ:NEOG), an innovative leader in food safety solutions, announced today that it has appointed Thierry Bernard as a director to its Board, effective November 1, 2024.

"We are pleased to welcome Thierry Bernard to the Neogen Board of Directors and look forward to his guidance as the company continues in its commitment to fueling a brighter future for global food security," said Jim Borel, Neogen's Board Chair. "As a sitting CEO with a wealth of knowledge in science and technologies relevant to Neogen and its markets, we are confident that he will provide significant value to the Board during the company's continued growth."

Thierry Bernard is Chief Executive Officer of QIAGEN N.V. (NYSE:QGEN, Frankfurt Stock Exchange: QIA))), a leading global provider of sample-to-insight solutions that are used to transform biological materials into molecular insights. Mr. Bernard was named to the role in March 2020 after joining QIAGEN in 2015. Prior to his role at QIAGEN, Mr. Bernard spent 15 years with bioMérieux SA, where he held roles of increasing responsibility, most recently as Corporate Vice President, Global Commercial Operations, Investor Relations and the Greater China Region. He also held senior management roles in other leading international companies.

About Neogen

Neogen Corporation is committed to fueling a brighter future for global food security through the advancement of human and animal well-being. Harnessing the power of science and technology, Neogen has developed comprehensive solutions spanning the Food Safety, Livestock, and Pet Health & Wellness markets. A world leader in these fields, Neogen has a presence in over 140 countries with a dedicated network of scientists and technical experts focused on delivering optimized products and technology for its customers.

Contact

[email protected]

View original content to download multimedia:https://www.prnewswire.com/news-releases/neogen-announces-the-appointment-of-new-board-member-302263825.html

SOURCE Neogen Corporation

Get the next $NEOG alert in real time by email

Recent Analyst Ratings for

$NEOG

$QGEN

Company	Date	Price Target	Rating	Analyst
Qiagen N.V. $QGEN	4/4/2025		Buy → Neutral	Redburn Atlantic
Qiagen N.V. $QGEN	2/19/2025	$52.00 → $42.00	Outperform → Neutral	Robert W. Baird
Qiagen N.V. $QGEN	1/6/2025	$48.00	Overweight → Equal-Weight	Morgan Stanley
Neogen Corporation $NEOG	12/19/2024	$15.00	Buy	Guggenheim
Qiagen N.V. $QGEN	12/10/2024	$42.50 → $54.00	Hold → Buy	Jefferies
Qiagen N.V. $QGEN	10/17/2024	$49.00	Buy → Hold	HSBC Securities
Qiagen N.V. $QGEN	6/27/2024	$50.00	Peer Perform → Outperform	Wolfe Research
Qiagen N.V. $QGEN	12/19/2023	$44.00	Equal Weight	Wells Fargo

More analyst ratings

Neogen Announces the Appointment of New Board Member

Chat with this insight

Recent Analyst Ratings for $NEOG$QGEN

$NEOG$QGEN Insider Purchases

Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

Director Woteki Catherine E bought $29,831 worth of shares (5,770 units at $5.17), increasing direct ownership by 77% to 13,244 units (SEC Form 4)

Director Borel James C bought $149,700 worth of shares (30,000 units at $4.99), increasing direct ownership by 50% to 90,474 units (SEC Form 4)

Director Boehm William T bought $26,175 worth of shares (5,000 units at $5.24), increasing direct ownership by 16% to 36,214 units (SEC Form 4)

$NEOG$QGEN Analyst Ratings

Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

Qiagen downgraded by Redburn Atlantic

Qiagen downgraded by Robert W. Baird with a new price target

Qiagen downgraded by Morgan Stanley with a new price target

$NEOG$QGEN Press Releases

Fastest customizable press release news feed in the world

QIAGEN announces plans for transition in leadership of Supervisory Board

QIAGEN delivers solid Q1 2025 results exceeding outlook; will seek shareholder approval to initiate a dividend and new $500 mn repurchase

QIAGEN to Propose Initiation of Annual Cash Dividend for Shareholder Approval at Annual General Meeting

$NEOG$QGEN SEC Filings

Neogen Corporation filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits

SEC Form 10-Q filed by Neogen Corporation

Neogen Corporation filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits

$NEOG$QGEN Insider Trading

Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

Chief Accounting Officer Moylan John Patrick exercised 4,558 shares at a strike of $5.15 and covered exercise/tax liability with 1,603 shares, increasing direct ownership by 30% to 12,955 units (SEC Form 4)

CEO Adent John Edward exercised 2,112 shares at a strike of $5.16, increasing direct ownership by 0.78% to 271,276 units (SEC Form 4)

Chief Operating Officer Jones Douglas Edward exercised 845 shares at a strike of $5.16 and covered exercise/tax liability with 291 shares, increasing direct ownership by 0.78% to 71,713 units (SEC Form 4)

$NEOG$QGEN Leadership Updates

Live Leadership Updates

Neogen® Announces CEO Transition

DoorDash, TKO Group Holdings, Williams-Sonoma and Expand Energy Set to Join S&P 500; Others to Join S&P 100, S&P MidCap 400 and S&P SmallCap 600